NeuroMetrix Overview
- Founded
- 1996
- Status
- Public
- Employees
- 23
- Stock Symbol
- NURO
- Investments
- 2
- Share Price
- $4.38
- (As of Tuesday Closing)
NeuroMetrix General Information
Description
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment of being Medical equipment and consumables.
Contact Information
Website
www.neurometrix.com
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Therapeutic Devices
Other Industries
Diagnostic Equipment
Stock Exchange
NAS
Primary Office
- 4b Gill Street
- Woburn, MA 01801
- United States
+1 (781) 000-0000
NeuroMetrix Stock Performance
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.38 | $4.48 | $2.70 - $38.75 | $31.2M | 7.13M | 1.57M | -$0.56 |
NeuroMetrix Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 7,051 | 10,971 | 8,209 | 2,624 |
| Revenue | 8,400 | 8,253 | 7,378 | 9,273 |
| EBITDA | (3,113) | (2,205) | (2,002) | (3,649) |
| Net Income | (3,180) | (2,281) | (2,092) | (3,773) |
| Total Assets | 26,248 | 24,888 | 7,995 | 6,894 |
| Total Debt | 432 | 535 | 1,061 | 1,505 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
NeuroMetrix Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore NeuroMetrix‘s full profile, request access.
Request a free trialNeuroMetrix Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capa
Therapeutic Devices
Woburn, MA
23
As of 2021
00000
000000000
00000
000 0000
smod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exerc
00000000000 0000000
Lewisville, TX
0000
As of 0000
00000
0.000
0000-00-00
000000&0
00000
00000-00
lum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa q
00000000000 0000000
Mineral Wells, TX
00
As of 0000
000000000 -
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialNeuroMetrix Competitors (41)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| DJO Global | Formerly PE-Backed | Lewisville, TX | 0000 | 00000 | 000000&0 | 00000 |
| 00000-0000 | Private Equity-Backed | Mineral Wells, TX | 00 | 000000000 - | ||
| 00000000 0000000 | Corporate Backed or Acquired | Stockton, CA | 000000&0 | |||
| 00000000 | Venture Capital-Backed | Pompano Beach, FL | 000 | 00000 | 00000000000 | 00000 |
| 000000000 | Formerly PE-Backed | Durham, NC | 0000 | 00000 | 00000000 | 00000 |
NeuroMetrix Patents
NeuroMetrix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200179694-A1 | Intelligent determination of therapeutic stimulation intensity for transcutaneous electrical nerve stimulation | Pending | 07-Dec-2018 | 0000000000 | |
| US-20140309709-A1 | Transcutaneous electrical nerve stimulator with automatic detection of user sleep-wake state | Granted | 15-Apr-2013 | 00000000000 | 00 |
| US-10279179-B2 | Transcutaneous electrical nerve stimulator with automatic detection of user sleep-wake state | Active | 15-Apr-2013 | 00000000000 | 00 |
| US-20200023182-A1 | Transcutaneous electrical nerve stimulator with automatic detection of user sleep-wake state | Pending | 15-Apr-2013 | 00000000000 | |
| US-20180140834-A1 | Transcutaneous electrical nerve stimulator with user gesture detector and electrode-skin contact detector, with transient motion detector for increasing the accuracy of the same | Granted | 29-Mar-2013 | A61N1/36021 |
NeuroMetrix Executive Team (6)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Shai Gozani MD | Chief Executive Officer & Chairman | ||
| Thomas Higgins | Chief Financial Officer, Finance & Chief Accounting Officer, Accounting |
NeuroMetrix Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000 0000000 00 | NeuroMetrix | Board Member | 000 0000 |
| 00000 000 000000000 | NeuroMetrix | Board Member | 000 0000 |
| 00000 0000 | Self | Board Member | 000 0000 |
| 0000 000000 00 | NeuroMetrix | Chief Executive Officer & Chairman | 000 0000 |
NeuroMetrix Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialNeuroMetrix Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 0000 0 | 01-Jan-2009 | 0000000000 | 00000 | Biotechnology | 0000 0000 |
| Eyetel Imaging | 26-Dec-2007 | Merger/Acquisition | 00000 | Diagnostic Equipment |